Table 3.
Impact of COVID-19 pandemic on study participants.
| Item | All participants(N = 2158) | Intention to receive COVID-19 vaccine | ||
|---|---|---|---|---|
| Vaccine hesitancy(n = 519) | Vaccine acceptance(n = 1639) | P value | ||
| Risk of COVID-19 infection | 0.001 | |||
| Unknown | 411 (19.05%) | 130 (25.05%) | 281 (17.14%) | |
| Low | 893 (41.38%) | 194 (37.38%) | 699 (42.65%) | |
| Medium | 440 (20.39%) | 105 (20.23%) | 335 (20.44%) | |
| High | 414 (19.18%) | 90 (17.34%) | 324 (19.77%) | |
| Impact of COVID-19 pandemic on regular medical treatment of cancer | < 0.001 | |||
| None | 281 (13.02%) | 97 (18.69%) | 184 (11.23%) | |
| Mild | 517 (23.96%) | 96 (18.50%) | 421 (25.69%) | |
| Moderate | 627 (29.05%) | 153 (29.48%) | 474 (28.92%) | |
| Severe | 733 (33.97%) | 173 (33.33%) | 560 (34.17%) | |
| Impact of COVID-19 pandemic on daily life | < 0.001 | |||
| None | 240 (11.12%) | 92 (17.73%) | 148 (9.03%) | |
| Mild | 526 (24.37%) | 99 (19.08%) | 427 (26.05%) | |
| Moderate | 693 (32.11%) | 169 (32.56%) | 524 (31.97%) | |
| Severe | 699 (32.39%) | 159 (30.64%) | 540 (32.95%) | |
| Impact of COVID-19 pandemic on income | < 0.001 | |||
| None | 532 (24.65%) | 208 (40.08%) | 324 (19.77%) | |
| Mild | 539 (24.98%) | 103 (19.85%) | 436 (26.60%) | |
| Moderate | 542 (25.12%) | 113 (21.77%) | 429 (26.17%) | |
| Severe | 545 (25.25%) | 95 (18.30%) | 450 (27.46%) | |
Data are presented as number (percentage). P values were calculated via chi-squared tests between the “vaccine hesitancy” and “vaccine acceptance” groups. Participants who had received or were willing to receive the COVID-19 vaccine were included in the “vaccine acceptance” group, and those who had not received or were unwilling to receive the COVID-19 vaccine were included in the “vaccine hesitancy” group. COVID-19: coronavirus disease 2019.